testosterone undecanoate has been researched along with Hypogonadism in 126 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (8.73) | 18.7374 |
| 1990's | 5 (3.97) | 18.2507 |
| 2000's | 27 (21.43) | 29.6817 |
| 2010's | 71 (56.35) | 24.3611 |
| 2020's | 12 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Bracken, K; Conway, AJ; Desai, R; Grossmann, M; Handelsman, DJ; Inder, WJ; Jesudason, D; Ly, LP; Shankara-Narayana, N; Stuckey, BGA; Wittert, GA; Yeap, BB | 1 |
| Diaz, P; Muthigi, A; Patel, M; Ramasamy, R; Reddy, R; Rivero, MJ | 1 |
| Amory, JK; Dudley, RE; Gittelman, M; Honig, S; Kaminetsky, J; Newmark, J; Rohowsky, N; Swerdloff, R; Wang, C; Woun Seo, B | 1 |
| Bates, A; Chandan, JS; Kauser, S; Kempegowda, P; Quinn, LM; Rahim, A; Shepherd, L | 1 |
| Doros, G; Haider, A; Haider, KS; Saad, F | 1 |
| Danoff, TM; Dudley, RE; Gittelman, MC; Kaminetsky, J; Longstreth, JA; Swerdloff, RS; Wang, C; White, WB | 1 |
| Dandona, P; Dhindsa, S; Doros, G; Haider, A; Haider, KS; Hanefeld, M; Saad, F; Traish, A | 1 |
| Geng, Q; Hao, BJ; Li, YZ; Liang, WN; Shang, XJ; Wu, M | 1 |
| Bondarenko, A; Borisov, P; Tishova, Y; Tsimafeyeu, I; Zakurdaeva, K; Zukov, R | 1 |
| Bush, M; Curd, L; Hu, Y; Pastuszak, AW; Priestley, T; Vijayan, S; Xiang, Q | 1 |
| Doros, G; Haider, A; Haider, KS; Traish, A | 1 |
| Cole, N; Hackett, G; Jones, P; Ramachandran, S; Saghir, A; Strange, RC | 2 |
| Ernst, M; Gooren, L; Keipert, D; Motazedi, H; Nettleship, J; Wolf, J | 1 |
| Chen, LP; Liu, JH; Lu, HL; Rao, K; Wang, T; Xu, H; Yang, J; Yuan, HX | 1 |
| Breza, J; Dubravicky, J; Fillo, J; Kovacova, E; Levcikova, M; Luha, J | 1 |
| Aftab, S; Ali, A; Barber, TM; Dimitriadis, GK; Grammatopoulos, DK; Hattersley, JG; Jones, TH; Mastorakos, G; Pandey, S; Randeva, HS; Valsamakis, G | 1 |
| Conway, A; Curtis, D; Goebel, C; Handelsman, DJ; Jayadev, V; Lim, S; Savkovic, S; Turner, L | 1 |
| Chen, XG; Gui, DW; Mao, JB; Peng, W; Zheng, J | 1 |
| DI, HJ; Fan, YF; Liu, C; Liu, KM; Zhang, HF | 1 |
| Denisova, IA; Morgunov, LY; Rozhkova, TI; Skvortsova, VI; Stakhovskaya, LV | 1 |
| Bai, F; Ceponis, J; Danoff, T; Dudley, R; Hull, L; Leung, A; Longstreth, J; Swerdloff, R; Wang, C | 1 |
| Caliber, M; Doros, G; Garvey, WT; Haider, A; Haider, KS; Saad, F; Yassin, A | 1 |
| Doros, G; Haider, A; Saad, F; Traish, A | 1 |
| Bang, JK; Choi, J; Hong, JY; Lim, JJ; Park, DS; Song, SH; Won, HJ; Yoon, TK | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Wilkinson, P | 2 |
| Burnett, AL; Madden, W; Morrison, BF; Reid, M | 1 |
| Huang, CC; Li, GY; Liang, JH; Liang, SK; Meng, ZB; Shen, SL; Song, WR; Wei, GQ; Zhang, X; Zhu, CH | 1 |
| Li, TL; Weng, ZW; Zhou, SH | 1 |
| del Rio, L; di Gregorio, S; Franco Miranda, E; Rodriguez-Tolrà, J; Torremadé Barreda, J | 1 |
| Almeida, M; Corrales, JJ; Martín-Martín, L; Miralles, JM; Orfao, A | 1 |
| Doros, G; Haider, A; Saad, F; Traish, AM | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Ilacqua, A; Lenzi, A | 1 |
| Morales, A | 1 |
| Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Conaglen, HM; Conaglen, JV; Elston, MS; Kamp, J; Paul, RG; Yarndley, T | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Saghir, A; Wilkinson, P | 1 |
| Harris O'Hanlon, L | 1 |
| Aversa, A; Barbaro, G; Bruzziches, R; Francomano, D; Lenzi, A | 1 |
| Fuqua, JS; Lee, PA; Watson, S | 1 |
| Doros, G; Hammerer, PG; Yassin, AA; Yassin, DJ | 1 |
| Doros, G; Haider, A; Hammerer, P; Isbarn, H; Yassin, A; Zitzmann, M | 1 |
| Corona, G; Maggi, M; Maseroli, E | 1 |
| Nieschlag, E | 1 |
| Shakhmanaev, AA; Vertkin, AL | 1 |
| Doros, G; Gooren, L; Haider, A; Saad, F; Yassin, A | 1 |
| Ma, J; Shang, XJ; Shen, XB; Shi, YJ; Zheng, Y; Zhou, YZ | 1 |
| Doros, G; Fijak, M; Gooren, L; Haider, A; Kurtz, W; Nasser, M; Saad, F; Vignozzi, L | 1 |
| Bouloux, PM; Elbers, JM; Geurts, TB; Johnson-Levonas, AO; Kaspers, MJ; Legros, JJ; Meehan, AG; Meuleman, EJ | 1 |
| Gilowski, W; Krysiak, R; Okopien, B | 1 |
| Chatterjee, S; Sanyal, D | 1 |
| Carbone, MD; De Pergola, G; Giagulli, VA; Guastamacchia, E; Licchelli, B; Ramunni, MI; Sabbà, C; Triggiani, V | 1 |
| Kim, JY; Park, JK; Shin, YS; Zhang, LT | 1 |
| Bouloux, PM; Gan, EH; Quinton, R | 1 |
| Almehmadi, Y; Nettleship, J; Saad, F; Salman, M; Yassin, AA | 1 |
| Doros, G; Haider, A; Haider, KS; Rosano, GM; Saad, F; Yassin, A | 1 |
| Almehmadi, Y; Nettleship, JE; Salman, M; Yassin, AA | 1 |
| Khupulsup, K; Leelaphiwat, S; Pavavattananusorn, S; Permpongkosol, S; Petchthong, T; Thongpradit, S | 1 |
| Albareda, M; Chillarón, JJ; Colom, C; Fernández-Miró, M; Flores Le-Roux, JA; Fontserè, S; Pedro-Botet, J; Vila, L | 1 |
| Gooren, LJ; Haide, A; Saad, F; Yassin, A | 1 |
| Christoph, A; Ernst, M; Freude, S; Gouni-Berthold, I; Hübler, D; Jockenhövel, F; Krone, W; Mellinger, U; Minnemann, T; Oettel, M; Schubert, M; Schumann, C | 1 |
| Dobs, AS; Kaufman, JM; Miner, MM; Morgentaler, A; Shabsigh, R; Swerdloff, RS; Wang, C | 1 |
| Christoph, A; Ernst, M; Freude, S; Hübler, D; Jockenhövel, F; Minnemann, T; Schubert, M; Schumann, C | 1 |
| Gamidov, SI; Mazo, EB; Sotnikova, EM | 1 |
| Frank, MA; Gomzhin, AI; Zhuravlev, VN | 1 |
| Gooren, LJ; Haider, A; Padungtod, P; Saad, F | 2 |
| Agledahl, I; Brodin, E; Hansen, JB; Svartberg, J | 1 |
| Conway, AJ; Fennell, C; Handelsman, DJ; Liu, PY; Ly, LP; Sartorius, G; Turner, L | 1 |
| Coral, MH; Hohl, A; Marques, MO; Walz, R | 1 |
| Fan, XB; Huang, YF | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Lenzi, A; Spera, G | 1 |
| Ahn, TY; Kim, JJ; Kim, SW; Lee, JY; Lee, SW; Moon, DG; Paick, JS; Park, JK; Park, K; Park, MG; Park, NC; Seo, JT; Yang, DY | 1 |
| Basaria, S; Edelstein, D | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Isidori, AM; Lenzi, A; Rosano, G; Spera, G | 1 |
| Giltay, EJ; Gooren, LJ; Kalinchenko, SY; Mskhalaya, GJ; Saad, F; Tishova, YA | 1 |
| Permpongkosol, S; Ratana-olarn, K; Tantirangsee, N | 1 |
| Brabrand, S; Cvancarova, M; Fosså, SD; Lehne, G | 1 |
| Escovar, P; Fraile, C; Garcia, JA; Sanchez, PE | 1 |
| Ho, CC; Khoo, EM; Lee, VK; Low, WY; Ng, CJ; Tan, HM; Tong, SF; Zainuddin, ZM | 1 |
| Amaya García, MJ; Enciso Izquierdo, FJ; Moyano Calvente, SL; Sánchez Fuentes, S | 1 |
| Aversa, A; Bruzziches, R; Di Luigi, L; Fornari, R; Francomano, D; Greco, EA; Lenzi, A; Migliaccio, S | 1 |
| Li, J; Li, WX; Luo, L; Wang, S; Wang, XK | 1 |
| Angelova, P; Kamenov, Z; Momchilova, A; Pankov, R; Petkova, D; Staneva, G | 1 |
| Gooren, L; Hanisch, J; Jones, H; Maggi, M; Mattern, A; Zitzmann, M | 1 |
| Kumar, N; Nieschlag, E; Sitruk-Ware, R | 1 |
| Miller, M; Quinton, R; Santhakumar, A | 1 |
| Bullmann, C; Jockenhövel, F; Krone, W; Minnemann, T; Reiners, C; Schubert, M | 1 |
| Chung, JM; Lee, KM; Park, NC; Yan, BQ | 1 |
| Köhn, FM; Schill, WB | 1 |
| Christoph, A; Ernst, M; Hübler, D; Jockenhövel, F; Krone, W; Mellinger, U; Minnemann, T; Oettel, M; Rouskova, D; Schubert, M | 1 |
| Basaria, S; Dobs, AS; Harle, L | 1 |
| Fottner, C; Weber, MM | 1 |
| Saad, F; Traish, A; Yassin, AA | 1 |
| Saad, F; Yassin, AA | 2 |
| Morales, A; Nieschlag, E; Oettel, M; Schubert, M; Yassin, AA; Zitzmann, M | 1 |
| Bagchus, W; Geurts, TB; Lass, H; Schnabel, PG; Thomsen, T | 1 |
| Behre, HM; Gooren, L; Jockenhel, F; Kamischke, A; Nieschlag, E; Saad, F; Schubert, M; Yassin, A; Zitzmann, M | 1 |
| Nieschlag, E; Zitzmann, M | 1 |
| Ernst, M; Freude, S; Gouni-Berthold, I; Hübler, D; Jockenhövel, F; Krone, W; Mellinger, U; Minnemann, T; Oettel, M; Schubert, M; Schumann, C; Sommer, F | 1 |
| Geurts, P; Jungwirth, A; Plas, E | 1 |
| Moisey, R; Orme, S; Swinburne, J | 1 |
| Behre, HM; Gooren, LJ | 1 |
| Freischem, CW; Nieschlag, E; Schürmeyer, T; Wickings, EJ | 1 |
| Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M | 1 |
| Bancroft, J; Davidson, DW; Skakkebaek, NE; Warner, P | 1 |
| Bingham, J; Chakraborty, J; English, J; Maisey, NM; Marks, V | 1 |
| Krempl, S; Mies, R | 1 |
| Heaton, JP; Johnston, B; Lundie, M; Morales, A | 1 |
| Jockenhövel, F; Reinhardt, W; Reinwein, D; Vogel, E | 1 |
| Abshagen, K; Behre, HM; Hübler, D; Nieschlag, E; Oettel, M | 1 |
| Abshagen, K; Behre, HM; Büchter, D; Nieschlag, E; Simoni, M; Von Eckardstein, S | 1 |
| Bauduceau, B; Bordier, L; Dupuy, O; Garcin, JM; Mayaudon, H; Palou, M; Sarret, D | 1 |
| Lawrence, DM; Sarris, S; Swyer, GI | 1 |
| Coert, A; Hirschhäuser, C; Hopkinson, CR; Sturm, G | 1 |
| Baldini, A; Carani, C; Della Casa, L; Ghizzani, A; Marrama, P; Zini, D | 1 |
| Gooren, LJ | 1 |
| Hampl, R; Hána, V; Marek, J; Mellanová, A; Stárka, L | 1 |
| Bancroft, J; O'Carroll, R; Shapiro, C | 1 |
16 review(s) available for testosterone undecanoate and Hypogonadism
| Article | Year |
|---|---|
Treatment of hypogonadism in males.
Topics: Adolescent; Androgens; Child; Humans; Hypogonadism; Male; Puberty, Delayed; Testosterone | 2014 |
A long-acting depot formulation of testosterone (Aveed).
Topics: Androgens; Animals; Chemistry, Pharmaceutical; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Hypogonadism; Male; Testosterone; Time Factors | 2014 |
Injectable testosterone undecanoate for the treatment of hypogonadism.
Topics: Androgens; Body Mass Index; Clinical Trials as Topic; Humans; Hypogonadism; Injections, Intramuscular; Penile Erection; Testosterone | 2014 |
Current topics in testosterone replacement of hypogonadal men.
Topics: Administration, Topical; Androgens; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Testosterone; Treatment Outcome | 2015 |
[Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis].
Topics: Androgens; Hemoglobin A; Humans; Hypogonadism; Luteinizing Hormone; Male; Prostate-Specific Antigen; Randomized Controlled Trials as Topic; Sex Hormone-Binding Globulin; Testosterone | 2015 |
[Testosterone undecanoate for late -onset hypogonadism: an update].
Topics: Erectile Dysfunction; Humans; Hypogonadism; Male; Testosterone | 2010 |
Testosterone undecanoate in the treatment of male hypogonadism.
Topics: Androgens; Animals; Delayed-Action Preparations; Drug Administration Schedule; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Testosterone; Treatment Outcome | 2010 |
[Hypogonadism and cardiovascular diseases in men].
Topics: Androgens; Cardiovascular Diseases; Humans; Hypogonadism; Male; Testosterone | 2011 |
7α-methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism.
Topics: Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Humans; Hypogonadism; Male; Nandrolone; Testosterone | 2013 |
A new oral testosterone undecanoate formulation.
Topics: Administration, Oral; Humans; Hypogonadism; Male; Testosterone; Testosterone Congeners | 2003 |
Testosterone Undecanoate-Schering AG.
Topics: Adult; Clinical Trials, Phase II as Topic; Humans; Hypogonadism; Male; Oligospermia; Testosterone | 2004 |
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.
Topics: Delayed-Action Preparations; Drugs, Investigational; Humans; Hypogonadism; Injections, Intramuscular; Male; Testosterone | 2005 |
[The latest developments in endocrinology 2004/2005].
Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed | 2006 |
Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).
Topics: Aging; Delayed-Action Preparations; Erectile Dysfunction; Humans; Hypogonadism; Male; Testosterone; Testosterone Congeners | 2006 |
More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate.
Topics: Contraceptive Agents, Male; Erectile Dysfunction; Humans; Hypogonadism; Injections, Intramuscular; Male; Testosterone; Testosterone Congeners | 2007 |
Testosterone treatment of hypogonadal men participating in competitive sports.
Topics: Athletic Performance; Doping in Sports; Humans; Hypogonadism; Injections, Intramuscular; Male; Muscle Strength; Safety; Sports; Sports Medicine; Testosterone | 2008 |
51 trial(s) available for testosterone undecanoate and Hypogonadism
| Article | Year |
|---|---|
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Follicle Stimulating Hormone; Follow-Up Studies; Genitalia, Male; Glucose Intolerance; Humans; Hypogonadism; Injections; Luteinizing Hormone; Male; Middle Aged; Quality of Life; Recovery of Function; Sexual Behavior; Testosterone; Withholding Treatment | 2022 |
Patient Satisfaction After Switching to Jatenzo (Oral Testosterone Undecanoate): Update on an Open-label, Single-arm Clinical Trial.
Topics: Humans; Hypogonadism; Injections, Intramuscular; Male; Patient Satisfaction; Testosterone | 2023 |
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety.
Topics: Adolescent; Adult; Aged; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Penile Erection; Testosterone; Young Adult | 2022 |
A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Drug Administration Schedule; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Solutions; Testosterone; Treatment Outcome; United States; Young Adult | 2020 |
[Jiarong Tablets combined with Testosterone Undecanoate Capsules for late-onset hypogonadism in males: A multicentered clinical trial].
Topics: Adult; Capsules; Drugs, Chinese Herbal; Humans; Hypogonadism; Male; Middle Aged; Tablets; Testosterone; Treatment Outcome | 2020 |
Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma: A Phase 2 Randomized Study FARETES.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Fatigue; Follow-Up Studies; Humans; Hypogonadism; Indazoles; Kidney Neoplasms; Male; Middle Aged; Pyrimidines; Quality of Life; Sulfonamides; Sunitinib; Testosterone | 2021 |
Population Pharmacokinetic Modeling and Simulations to Evaluate a Potential Dose Regimen of Testosterone Undecanoate in Hypogonadal Males.
Topics: Adult; Aged; Body Weight; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Models, Biological; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2021 |
Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Hormone Replacement Therapy; Humans; Hypogonadism; Libido; Male; Middle Aged; Penile Erection; Testosterone; Young Adult | 2017 |
[Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males].
Topics: Androgens; Capsules; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Hypogonadism; Male; Middle Aged; Testosterone | 2017 |
[Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].
Topics: Androgens; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Lipids; Male; Testosterone; Waist Circumference | 2017 |
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Topics: Adult; Affect; Aged; Aged, 80 and over; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; England; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Quality of Life; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2013 |
[Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED].
Topics: Adult; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Tadalafil; Testosterone; Treatment Outcome | 2013 |
[The method of tonifying kidneys and activating blood circulation increases testosterone secretion index in late-onset hypogonadism males with kidney deficiency].
Topics: Adult; Aged; Humans; Hypogonadism; Luteinizing Hormone; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Testis; Testosterone; Treatment Outcome | 2013 |
Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome.
Topics: Absorptiometry, Photon; Androgens; Body Composition; Dosage Forms; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone; Time; Treatment Outcome; Waist-Hip Ratio | 2013 |
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Topics: Adult; Aged; Androgens; Body Composition; Body Mass Index; Delayed-Action Preparations; Depressive Disorder; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone; Young Adult | 2014 |
The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Topics: Adult; Aged; Aged, 80 and over; Androgens; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Humans; Hypoglycemic Agents; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome | 2014 |
[Optimization of the treatment of chronic obstructive pulmonary disease in men with androgen deficiency].
Topics: Androgens; Comorbidity; Delayed-Action Preparations; Depression; Drug Monitoring; Humans; Hypogonadism; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Risk Factors; Russia; Testosterone; Treatment Outcome | 2014 |
Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.
Topics: Administration, Oral; Aged; Aging; Androgens; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 2015 |
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgens; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypogonadism; Male; Middle Aged; Penile Erection; Severity of Illness Index; Sexuality; Testosterone; Time Factors; Young Adult | 2016 |
Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.
Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Hypogonadism; Lipid Metabolism; Lipids; Male; Metabolic Syndrome; Middle Aged; Spain; Testosterone | 2016 |
Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
Topics: Aging; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Testosterone | 2008 |
Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism.
Topics: Adolescent; Adult; Aged; Body Mass Index; Chemistry, Pharmaceutical; Delayed-Action Preparations; Hand Strength; Humans; Hypogonadism; Injections, Intramuscular; Leptin; Lipids; Male; Middle Aged; Testosterone; Waist-Hip Ratio; Young Adult | 2008 |
Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men.
Topics: Adolescent; Adult; Affect; Aged; Delayed-Action Preparations; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Patient Satisfaction; Penile Erection; Sexual Behavior; Testosterone; Young Adult | 2009 |
[Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
Topics: Drug Therapy, Combination; Endothelium, Vascular; Erectile Dysfunction; Homocysteine; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Risk Factors; Sulfones; Testosterone; Treatment Outcome; Triazines; Vardenafil Dihydrochloride | 2008 |
Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
Topics: Aged; Antigens; Cardiovascular Diseases; Case-Control Studies; Delayed-Action Preparations; Double-Blind Method; Factor VII; Follow-Up Studies; Humans; Hypogonadism; Injections, Intramuscular; Lipids; Lipoproteins; Male; Middle Aged; Risk Factors; Testosterone; Thrombin; Thrombophilia; Thromboplastin; Time Factors | 2009 |
Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
Topics: Androgens; Cross-Over Studies; Drug Implants; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Patient Satisfaction; Quality of Life; Testosterone | 2010 |
Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone.
Topics: Analysis of Variance; Androgens; Andropause; Brazil; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 2009 |
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome.
Topics: Administration, Oral; Body Composition; Humans; Hypogonadism; Injections, Intramuscular; Insurance, Pharmaceutical Services; Italy; Male; Metabolic Syndrome; Middle Aged; Penile Erection; Testosterone | 2010 |
The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
Topics: Adult; Aged; Androgens; Cross-Cultural Comparison; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Korea; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2010 |
Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
Topics: Androgens; Atherosclerosis; Blood Glucose; Blood Pressure; Body Composition; Cardiovascular Diseases; Double-Blind Method; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Testosterone; Waist Circumference | 2010 |
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Humans; Hypogonadism; Inflammation; Insulin; Interleukin-10; Interleukin-6; Leptin; Lipids; Male; Metabolic Syndrome; Middle Aged; Testosterone; Tumor Necrosis Factor-alpha; Waist Circumference; Waist-Hip Ratio | 2010 |
Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Phosphodiesterase 5 Inhibitors; Testosterone | 2011 |
A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
Topics: Adult; Aged; Analysis of Variance; Androgens; Double-Blind Method; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Quality of Life; Severity of Illness Index; Syndrome; Testosterone | 2012 |
Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Topics: Aged; Androgens; Bone Density; Femur; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Spine; Testosterone | 2012 |
[Tadalafil improves total testosterone, IIEF score and SEP in old and middle-aged males with late-onset hypogonadism].
Topics: Carbolines; Erectile Dysfunction; Humans; Hypogonadism; Male; Middle Aged; Sexual Behavior; Tadalafil; Testosterone; Treatment Outcome | 2012 |
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Topics: Adult; Androgens; Delayed-Action Preparations; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Testosterone | 2013 |
Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
Topics: Adult; Aged; Androgens; Bone Density; Dihydrotestosterone; Double-Blind Method; Drug Implants; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Mesterolone; Middle Aged; Osteoporosis; Prospective Studies; Steroids; Testosterone | 2003 |
Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.
Topics: Administration, Oral; Humans; Hypogonadism; Male; Quality of Life; Single-Blind Method; Testosterone; Testosterone Congeners | 2003 |
Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2004 |
The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.
Topics: Aged; Area Under Curve; Biological Availability; Cross-Over Studies; Dietary Fats, Unsaturated; Female; Hormone Replacement Therapy; Humans; Hypogonadism; Intestinal Absorption; Middle Aged; Postmenopause; Testosterone; Testosterone Congeners | 2007 |
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
Topics: Adult; Body Mass Index; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Nonlinear Dynamics; Obesity; Pharmacogenetics; Receptors, Androgen; Regression Analysis; Testosterone; Testosterone Congeners; Trinucleotide Repeats | 2007 |
Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 2007 |
Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
Topics: Adult; Clinical Trials as Topic; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 1981 |
Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Hypogonadism; Libido; Male; Methyltestosterone; Middle Aged; Testosterone; Testosterone Congeners | 1997 |
Effects of various modes of androgen substitution therapy on erythropoiesis.
Topics: Adult; Dihydrotestosterone; Drug Implants; Erythropoiesis; Ferritins; Hematocrit; Hemoglobins; Humans; Hypogonadism; Iron; Male; Mesterolone; Regression Analysis; Testosterone; Testosterone Congeners | 1997 |
Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.
Topics: Adult; Blood Pressure; Body Weight; Estradiol; Gonadotropins; Hormones; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone; Testosterone Congeners | 1999 |
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
Topics: Adult; Analysis of Variance; Body Weight; Dihydrotestosterone; Ejaculation; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Testosterone undecanoate: a new orally active androgen.
Topics: 17-Ketosteroids; Administration, Oral; Adult; Androgens; Clinical Trials as Topic; Dihydrotestosterone; Fatty Acids; Humans; Hypogonadism; Male; Placebos; Stimulation, Chemical; Testosterone | 1975 |
Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Hypogonadism; Luteinizing Hormone; Male; Sexual Behavior; Testosterone | 1990 |
[Comparison of the effect of methyltestosterone and testosterone undecanoate in substitution therapy of hypogonadism].
Topics: Adolescent; Adult; Clinical Trials as Topic; Humans; Hypogonadism; Libido; Male; Methyltestosterone; Middle Aged; Self Concept; Testosterone | 1987 |
Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.
Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypogonadism; Male; Middle Aged; Penile Erection; Sexual Behavior; Sleep; Testosterone | 1985 |
59 other study(ies) available for testosterone undecanoate and Hypogonadism
| Article | Year |
|---|---|
Long-term testosterone undecanoate replacement therapy: Impact of ethnicity.
Topics: Ethnicity; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Retrospective Studies; Testosterone | 2020 |
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from
Topics: Aged; Anthropometry; Blood Pressure; Cardiovascular Diseases; Humans; Hypogonadism; Injections; Lipids; Longitudinal Studies; Male; Middle Aged; Mortality; Obesity; Overweight; Registries; Testosterone; Weight Loss | 2020 |
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypogonadism; Male; Registries; Testosterone | 2020 |
Jatenzo - an oral testosterone for hypogonadism.
Topics: Administration, Oral; Androgens; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Testosterone | 2021 |
Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study.
Topics: Aged; Androgens; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Penile Erection; Prospective Studies; Quality of Life; Registries; Testosterone; Treatment Outcome; Urinary Bladder; Urination | 2018 |
Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study.
Topics: Adolescent; Adult; Aged; Androgens; Drug Administration Schedule; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Testosterone; Young Adult | 2017 |
[Secondary male hypogonadism induced by sellar space-occupying lesion: Clinical analysis of 22 cases].
Topics: Adult; Chorionic Gonadotropin; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sella Turcica; Spermatogenesis; Spermatozoa; Testis; Testosterone; Tumor Burden | 2016 |
Testosterone replacement therapy (TRT) and its effect on bone marrow. How serious is it and is there a true polyglobulia?
Topics: Bone Marrow; Cross-Sectional Studies; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Syndrome; Testosterone | 2017 |
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
Topics: Adult; Blood Glucose; Body Composition; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Obesity; Phenotype; Pilot Projects; Prospective Studies; Testosterone; Treatment Outcome | 2018 |
Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Topics: Adolescent; Adult; Androgens; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Humans; Hypogonadism; Luteinizing Hormone; Male; Mass Spectrometry; Middle Aged; Testosterone; Transgender Persons; Transsexualism; Young Adult | 2018 |
Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus.
Topics: Aged; Biomarkers; Diabetes Mellitus, Type 2; Gonadal Steroid Hormones; Humans; Hypogonadism; Male; Middle Aged; Russia; Stroke; Testosterone | 2020 |
Accurate measurement of androgen after androgen esters: problems created by ex vivo esterase effects and LC-MS/MS interference.
Topics: Adolescent; Adult; Chromatography, Liquid; Esterases; Humans; Hypogonadism; Middle Aged; Nandrolone; Sodium Fluoride; Tandem Mass Spectrometry; Testosterone; Young Adult | 2019 |
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypogonadism; Male; Middle Aged; Prediabetic State; Registries; Testosterone; Triglycerides | 2019 |
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.
Topics: Adult; Aged; Body Mass Index; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Prospective Studies; Testosterone; Waist Circumference; Weight Loss | 2013 |
Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple.
Topics: Adult; Androgens; Azoospermia; Erectile Dysfunction; Humans; Hypogonadism; Infertility, Male; Male; Oligospermia; Testosterone | 2013 |
Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Topics: Adult; Anemia, Sickle Cell; Biomarkers; Genetic Predisposition to Disease; Hemoglobin, Sickle; Homozygote; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Jamaica; Male; Penile Erection; Pilot Projects; Priapism; Risk Factors; Surveys and Questionnaires; Testosterone; Time Factors; Treatment Outcome | 2013 |
Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells.
Topics: Adult; Dendritic Cells; Hormone Replacement Therapy; Humans; Hypogonadism; Lysosomal-Associated Membrane Protein 2; Male; Monocytes; Oligodeoxyribonucleotides; Testosterone | 2014 |
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.
Topics: Adult; Aged; Androgens; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Fasting; Glycated Hemoglobin; Humans; Hypogonadism; Lipid Metabolism; Long-Term Care; Male; Metabolic Syndrome; Middle Aged; Obesity; Organ Size; Prostate; Registries; Testosterone; Treatment Outcome; Triglycerides | 2014 |
Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome.
Topics: Aged; Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Obesity; Testosterone; Time Factors; Treatment Outcome | 2014 |
Editorial comment.
Topics: Androgens; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Obesity; Testosterone | 2014 |
Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Personal Satisfaction; Piperazines; Prospective Studies; Sexual Partners; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2014 |
Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Drug Implants; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Long-Term Care; Male; Middle Aged; Prostate-Specific Antigen; Reference Values; Retrospective Studies; Testosterone; Young Adult | 2014 |
FDA declines approval of testosterone drug for third time.
Topics: Drug Approval; Humans; Hypersensitivity; Hypogonadism; Male; Pulmonary Embolism; Testosterone; United States; United States Food and Drug Administration | 2013 |
Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
Topics: Blood Pressure; Body Composition; Cardiovascular System; Carotid Intima-Media Thickness; Diet, Reducing; Endothelium, Vascular; Exercise; Fibrinogen; Glucose Tolerance Test; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypogonadism; Lipids; Male; Middle Aged; Obesity; Pilot Projects; Testosterone | 2014 |
Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Topics: Aged; Androgens; Body Composition; Body Mass Index; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Erectile Dysfunction; Humans; Hypogonadism; Male; Metabolic Syndrome; Middle Aged; Obesity; Penile Erection; Prospective Studies; Quality of Life; Testosterone; Triglycerides; Waist Circumference | 2014 |
Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Follow-Up Studies; Humans; Hypogonadism; Incidence; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Registries; Testosterone; Time Factors | 2015 |
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.
Topics: Age Factors; Age of Onset; Aged; Androgens; Anthropometry; Drug Monitoring; Germany; Humans; Hypogonadism; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Registries; Sexual Behavior; Testosterone; Treatment Outcome | 2015 |
Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study.
Topics: C-Reactive Protein; Crohn Disease; Disease Progression; Germany; Humans; Hypogonadism; Inflammation; Leukocytes; Liver; Male; Prospective Studies; Syria; Testosterone; Transaminases | 2015 |
The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.
Topics: Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Dyslipidemias; Fenofibrate; Humans; Hypogonadism; Hypolipidemic Agents; Lipids; Male; Middle Aged; Prospective Studies; Risk Factors; Testosterone | 2015 |
Treatment preferences and outcome in male hypogonadotropic hypogonadism: an Indian perspective.
Topics: Adult; Chorionic Gonadotropin; Drug Costs; Drug Therapy, Combination; Fertility; Follicle Stimulating Hormone; Humans; Hypogonadism; India; Male; Patient Preference; Retrospective Studies; Spermatogenesis; Testis; Testosterone; Treatment Outcome; Young Adult | 2016 |
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypogonadism; Incretins; Liraglutide; Male; Metformin; Middle Aged; Obesity; Penile Erection; Retrospective Studies; Risk Reduction Behavior; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2015 |
Could Testosterone Replacement Therapy in Hypogonadal Men Ameliorate Anemia, a Cardiovascular Risk Factor? An Observational, 54-Week Cumulative Registry Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgens; Anemia; Cardiovascular Diseases; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Registries; Risk Factors; Testosterone; Time Factors; Young Adult | 2016 |
Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido(®) or Reandron(®) ) in men with congenital hypogonadotrophic hypogonadism.
Topics: Adult; Androgens; Humans; Hypogonadism; Injections, Intramuscular; Male; Testosterone | 2016 |
Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
Topics: Adult; Aged; Androgens; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; C-Reactive Protein; Cholesterol; Hormone Replacement Therapy; Humans; Hypogonadism; Lipoproteins, HDL; Male; Middle Aged; Prospective Studies; Registries; Testosterone; Triglycerides; Waist Circumference | 2016 |
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Germany; Health Status; Heart Rate; Hormone Replacement Therapy; Humans; Hypogonadism; Lipids; Male; Middle Aged; Recurrence; Registries; Secondary Prevention; Testosterone; Time Factors; Treatment Outcome; Waist Circumference; Weight Loss | 2016 |
Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Aging; Androgens; Body Mass Index; Body Weight; Cardiovascular Diseases; Erectile Dysfunction; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Obesity; Prospective Studies; Quality of Life; Reproductive Health; Risk Factors; Surveys and Questionnaires; Testosterone; Waist Circumference; Young Adult | 2017 |
Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Topics: Aged; Androgens; Bone Density; Drug Administration Schedule; Follow-Up Studies; Humans; Hypogonadism; Libido; Lipoproteins, HDL; Male; Middle Aged; Obesity; Orgasm; Patient Satisfaction; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Testosterone; Triglycerides; Waist Circumference | 2016 |
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
Topics: Adult; Aged; Aged, 80 and over; Humans; Hypogonadism; Male; Middle Aged; Testosterone; Testosterone Congeners | 2008 |
Sexual functions of men with obstructive sleep apnoea syndrome and hypogonadism may improve upon testosterone administration: a pilot study.
Topics: Adult; Continuous Positive Airway Pressure; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Pilot Projects; Piperazines; Sleep Apnea, Obstructive; Sulfones; Testosterone; Triazines; Vardenafil Dihydrochloride | 2009 |
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
Topics: Adult; Aged; Aging; Androgens; Body Mass Index; C-Reactive Protein; Cohort Studies; Fatty Liver; Humans; Hypogonadism; Liver; Male; Metabolic Syndrome; Middle Aged; Testosterone | 2010 |
Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Androgens; Body Composition; Body Mass Index; Health Status Indicators; Humans; Hypogonadism; Infusions, Parenteral; Lipids; Male; Middle Aged; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Surveys and Questionnaires; Testosterone; Time Factors | 2010 |
Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals.
Topics: Adult; Androgens; Epidemiologic Methods; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Testosterone; Treatment Outcome | 2011 |
A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months.
Topics: Adolescent; Adult; Aged; Humans; Hypogonadism; Male; Middle Aged; Polycythemia; Prostate-Specific Antigen; Testosterone | 2010 |
[46 XX Male syndrome].
Topics: Azoospermia; Chromosomes, Human, X; Chromosomes, Human, Y; Crossing Over, Genetic; Female; Genes, sry; Humans; Hypogonadism; Male; Middle Aged; Phenotype; Sex Chromosome Disorders of Sex Development; Sex-Determining Region Y Protein; Testosterone | 2012 |
Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men.
Topics: Adult; Ceramides; Erythrocyte Membrane; Humans; Hypogonadism; Lipid Metabolism; Male; Membrane Fluidity; Middle Aged; Phosphatidylethanolamines; Sphingomyelins; Testosterone; Thrombosis | 2012 |
Pubertal induction in adult males with isolated hypogonadotropic hypogonadism using long-acting intramuscular testosterone undecanoate 1-g depot (Nebido).
Topics: Adolescent; Adult; Humans; Hypogonadism; Male; Middle Aged; Puberty, Delayed; Retrospective Studies; Testosterone; Young Adult | 2014 |
Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Humans; Hypogonadism; Impotence, Vasculogenic; Male; Middle Aged; Penile Erection; Penis; Radiography; Regional Blood Flow; Testosterone; Treatment Outcome; Ultrasonography; Vasodilation; Vasodilator Agents | 2006 |
Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9-12 February 2006, Salzburg, Austria.
Topics: Aged; Aging; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Hormone Replacement Therapy; Humans; Hypogonadism; Injections; Male; Testosterone | 2006 |
A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate.
Topics: Adolescent; Adult; Aged; Germany; Humans; Hypogonadism; Infusions, Parenteral; Male; Middle Aged; Safety; Testosterone; Treatment Outcome | 2007 |
Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism.
Topics: Age of Onset; Aged; Austria; Humans; Hypogonadism; Male; Middle Aged; Prostate-Specific Antigen; Testosterone; Testosterone Congeners | 2007 |
Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Topics: Adolescent; Adult; Age Factors; Aged; Biological Availability; Body Size; Dose-Response Relationship, Drug; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Retrospective Studies; Testosterone; Treatment Outcome; Young Adult | 2008 |
Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men.
Topics: Adolescent; Adult; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Saliva; Testosterone | 1983 |
Which testosterone replacement therapy?
Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 1984 |
Clinical efficacy of testosterone undecanoate in male hypogonadism.
Topics: Administration, Oral; Drug Implants; Humans; Hypogonadism; Male; Testosterone | 1981 |
[Effect of testosterone undeconoate in male hypogonadism].
Topics: Adolescent; Adult; Humans; Hypogonadism; Male; Testosterone | 1980 |
[De La Chapelle syndrome].
Topics: Administration, Oral; Adult; Chi-Square Distribution; Cohort Studies; Diagnosis, Differential; Estradiol; Follicle Stimulating Hormone; Humans; Hypogonadism; Injections, Intramuscular; Karyotyping; Klinefelter Syndrome; Luteinizing Hormone; Male; Middle Aged; Phenotype; Prolactin; Retrospective Studies; Sex Chromosome Aberrations; Syndrome; Testosterone; Testosterone Congeners; Time Factors | 2001 |
Hypogonadal men treated with oral testosterone undecanoate.
Topics: Administration, Oral; Adolescent; Adult; Humans; Hypogonadism; Male; Testosterone | 1977 |
Androgen levels and sex functions in testosterone-treated hypogonadal men.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Dihydrotestosterone; Drug Combinations; Humans; Hypogonadism; Injections; Male; Methyltestosterone; Middle Aged; Sexual Behavior; Tamoxifen; Testosterone; Time Factors | 1987 |
Testosterone undecanoate--oral therapy for male hypogonadism.
Topics: Administration, Oral; Humans; Hypogonadism; Male; Testosterone | 1985 |